Literature DB >> 17140759

Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases.

K Tanaka1, H Shimada, K Matsuo, M Ueda, I Endo, S Togo.   

Abstract

AIMS: Two-stage hepatectomy for multiple, bilobar liver metastases from colorectal cancer aimed to minimize liver failure risk by performing the second resection after regeneration, but impact of this strategy on volume of the future liver remnant (FLR) remained to be demonstrated. We compared two-stage hepatectomy with one stage following portal vein embolization (PVE) for multiple, bilobar liver metastases from colorectal cancer as to effects on volume of the FLR.
METHODS: Forty-three patients undergoing major hepatectomy for multiple colorectal cancer metastases were divided retrospectively into patients undergoing hepatectomy following PVE (n=21) and those undergoing two-stage hepatectomy (n=22). Increases in FLR volume were compared.
RESULTS: While the increase in the volume FLR averaged approximately 70 mL (302.6 mL before PVE vs. 370.9 mL after PVE) and the increase in the ratio of FLR to total liver volume averaged approximately 7.5% (30.2% to 37.5%) following PVE, first-stage hepatectomy increased FLR volume by approximately 100mL (from 259.4 to 361.4), and the ratio, by 15% (26.9% to 41.6%). The FLR hypertrophy ratio relative to pre-procedure volume estimates in the two-stage group (50.2%) was twice that in the PVE group (25.3%).
CONCLUSIONS: Superiority of two-stage hepatectomy in hypertrophy of the FLR was confirmed.

Entities:  

Mesh:

Year:  2006        PMID: 17140759     DOI: 10.1016/j.ejso.2006.10.038

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  23 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

Review 2.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 3.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

Review 4.  Staged resection of bilobar colorectal liver metastases: surgical strategies.

Authors:  Cui Yang; Nuh N Rahbari; Sören Torge Mees; Felix Schaab; Moritz Koch; Jürgen Weitz; Christoph Reissfelder
Journal:  Langenbecks Arch Surg       Date:  2015-06-08       Impact factor: 3.445

5.  Comparison of various surgical approaches for extensive bilateral colorectal liver metastases.

Authors:  Christoph Reissfelder; Nuh N Rahbari; L Urrutia Bejarano; Thomas Schmidt; Nikolas Kortes; Hans-Ulrich Kauczor; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  Langenbecks Arch Surg       Date:  2014-03-11       Impact factor: 3.445

Review 6.  [Surgical treatment of liver metastases].

Authors:  M Loss; E M Jung; M N Scherer; S A Farkas; H J Schlitt
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

Review 7.  Associated liver partition and portal vein ligation for staged hepatectomy: a review.

Authors:  Kai Siang Chan; Jee Keem Low; Vishal G Shelat
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

8.  Is there new hope for patients with marginally resectable liver malignancies.

Authors:  Martin Loos; Helmut Friess
Journal:  World J Gastrointest Surg       Date:  2012-07-27

9.  Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases.

Authors:  Kuniya Tanaka; Takafumi Kumamoto; Ryusei Matsuyama; Kazuhisa Takeda; Yasuhiko Nagano; Itaru Endo
Journal:  J Gastrointest Surg       Date:  2009-11-03       Impact factor: 3.452

Review 10.  A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Authors:  Jin-Yao Teo; John C Allen; David C Ng; Su-Pin Choo; David W M Tai; Jason P E Chang; Foong-Khoon Cheah; Pierce K H Chow; Brian K P Goh
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.